DENTSPLY SIRONA (XRAY) Projected to Post Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) will likely be releasing its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect DENTSPLY SIRONA to post earnings of $0.45 per share and revenue of $900.3320 million for the quarter. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS.Individuals may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 6, 2025 at 8:30 AM ET.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the company earned $0.49 EPS. On average, analysts expect DENTSPLY SIRONA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $12.86 on Thursday. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company has a market capitalization of $2.57 billion, a PE ratio of -2.71, a price-to-earnings-growth ratio of 0.82 and a beta of 0.96. DENTSPLY SIRONA has a one year low of $11.69 and a one year high of $24.86. The business has a 50 day simple moving average of $13.28 and a 200 day simple moving average of $14.52.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Evercore ISI cut their target price on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research report on Wednesday, October 8th. Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Stifel Nicolaus cut their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. UBS Group cut their price objective on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a research report on Tuesday. Finally, Barrington Research reiterated an “outperform” rating and issued a $18.00 price objective on shares of DENTSPLY SIRONA in a research report on Wednesday. Two investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $17.91.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors and hedge funds have recently bought and sold shares of the business. State of Wyoming raised its stake in DENTSPLY SIRONA by 52.8% in the second quarter. State of Wyoming now owns 19,091 shares of the medical instruments supplier’s stock valued at $303,000 after buying an additional 6,596 shares during the period. Pitcairn Co. bought a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $160,000. CANADA LIFE ASSURANCE Co raised its stake in DENTSPLY SIRONA by 1.7% in the second quarter. CANADA LIFE ASSURANCE Co now owns 205,811 shares of the medical instruments supplier’s stock valued at $3,268,000 after buying an additional 3,352 shares during the period. Tower Research Capital LLC TRC raised its stake in DENTSPLY SIRONA by 26.7% in the second quarter. Tower Research Capital LLC TRC now owns 15,273 shares of the medical instruments supplier’s stock valued at $243,000 after buying an additional 3,219 shares during the period. Finally, Corient Private Wealth LLC bought a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $492,000. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.